Published in CMAJ on June 30, 1998
Recent advances: palliative care. BMJ (2000) 1.76
Bioethics for clinicians: 15. Quality end-of-life care. CMAJ (1998) 0.94
Application of quality audit tools to evaluate care quality received by terminal cancer patients admitted to a palliative care unit. Support Care Cancer (2008) 0.84
Prophylactic anti-coagulation in cancer palliative care: a prospective randomised study. Support Care Cancer (2007) 0.82
Palliative care for HIV disease in the era of highly active antiretroviral therapy. J Urban Health (2000) 0.81
Asthenia and paralysis. CMAJ (1998) 0.75
Pain and its treatment in outpatients with metastatic cancer. N Engl J Med (1994) 9.54
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med (1980) 6.12
Pharmacologic treatment of cancer pain. N Engl J Med (1996) 2.24
Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen. J Pain Symptom Manage (1996) 2.09
Subcutaneous morphine for dyspnea in cancer patients. Ann Intern Med (1993) 1.95
A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry (1996) 1.89
ABC of palliative care. Anorexia, cachexia, and nutrition. BMJ (1997) 1.44
Morphine intoxication during acute reversible renal insufficiency. J Palliat Care (1991) 1.43
Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer. J Pain Symptom Manage (1995) 1.40
Hospice and palliative care in the UK 1994-5, including a summary of trends 1990-5. Palliat Med (1997) 1.35
Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Cancer (1996) 1.33
Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study. Cancer (1998) 1.29
The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer (1997) 1.25
Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage (1992) 1.22
The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy. Respir Med (1995) 1.16
Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: the use of the N of 1 randomized controlled trial. J Pain Symptom Manage (1992) 1.05
Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease. Thorax (1996) 1.01
Pain management in osteoarthritis: the role of COX-2 inhibitors. J Rheumatol Suppl (1997) 1.01
Corticosteroids as adjuvant analgesics. J Pain Symptom Manage (1994) 0.97
Influence of the pain and symptom control team (PSCT) on the patterns of treatment of pain and other symptoms in a cancer center. J Pain Symptom Manage (1989) 0.97
A controlled study of sustained-release morphine sulfate tablets in chronic pain from advanced cancer. Am J Clin Oncol (1992) 0.92
Continuous intravenous infusion of morphine for severe dyspnea. South Med J (1991) 0.90
A review of the drug treatment of cachexia associated with cancer. Drugs (1998) 0.88
Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group. Ann Oncol (1997) 0.87
Anorexia and cachexia, asthenia, and lethargy. Hematol Oncol Clin North Am (1996) 0.84
The role of octreotide in palliative care. J Pain Symptom Manage (1994) 0.83
Matching the clinical function and symptom status with the expectations of patients with advanced cancer, their families, and health care workers. Support Care Cancer (1997) 0.81
Pain and Symptom Management in Palliative Care. Cancer Control (1996) 0.80
Brief electrical stimulation promotes the speed and accuracy of motor axonal regeneration. J Neurosci (2000) 2.43
Predictors of home death in palliative care cancer patients. J Palliat Care (2000) 1.46
A human health assessment of hazardous air pollutants in Portland, OR. J Environ Manage (2004) 1.23
Attitudes and beliefs of palliative care physicians regarding communication with terminally ill cancer patients. Palliat Med (2000) 1.18
Communication between primary care physicians and radiation oncologists regarding patients with cancer treated with palliative radiotherapy. J Clin Oncol (2000) 1.16
The addition of an audiocassette recording of a consultation to written recommendations for patients with advanced cancer: A randomized, controlled trial. Cancer (1999) 1.14
The frequency and correlates of dyspnea in patients with advanced cancer. J Pain Symptom Manage (2000) 1.06
Edmonton Regional Palliative Care Program: impact on patterns of terminal cancer care. CMAJ (1999) 1.05
The impact of a regional palliative care program on the cost of palliative care delivery. J Palliat Med (2000) 1.03
Multidisciplinary symptom control clinic in a cancer center: a retrospective study. Support Care Cancer (2001) 1.01
Opioid type and other clinical predictors of laxative dose in advanced cancer patients: a retrospective study. J Palliat Med (2000) 0.92
Thalidomide in patients with cachexia due to terminal cancer: preliminary report. Ann Oncol (1999) 0.87
The uses of psychotropics in symptom management in advanced cancer. Psychooncology (1998) 0.84
A randomized controlled trial of local injections of hyaluronidase versus placebo in cancer patients receiving subcutaneous hydration. Ann Oncol (1999) 0.82
Analysis of denatonium benzoate in Oregon consumer products by HPLC. Chemosphere (1998) 0.81
Daily journal club: an education tool in palliative care. Palliat Med (2002) 0.78
Bus rounds for medical congresses on palliative care. Support Care Cancer (1998) 0.77
Role of arachidonic acid and calmodulin in mediating dopamine D1- and GnRH-stimulated growth hormone release in goldfish pituitary cells. Gen Comp Endocrinol (1996) 0.76
Assessing Oregon's twenty-six coastal beach areas for recreational water quality standards. Mar Pollut Bull (2004) 0.76
Impact of the Edmonton Labeled Visual Information System on physician recall of metastatic cancer patient histories. a randomized controlled trial. J Pain Symptom Manage (2001) 0.75
Interactions between protein kinase C and arachidonic acid in the gonadotropin response to salmon and chicken gonadotropin-releasing hormone-II in goldfish. Gen Comp Endocrinol (1994) 0.75
A dose reconstruction of 60Co-contaminated window frames in a Taiwanese school. Health Phys (2001) 0.75
Signal transduction pathways in GnRH- and dopamine D1-stimulated growth hormone secretion in the goldfish. Chin J Physiol (1994) 0.75
The anaphylatoxin C5a, a new parameter in the diagnosis of renal allograft rejection. Transpl Int (1996) 0.75
Roles of calcium and calmodulin in the mediation of acute and sustained GnRH-stimulated gonadotropin secretion from dispersed goldfish pituitary cells. Gen Comp Endocrinol (1996) 0.75
Interactions between signaling pathways in mediating GnRH-stimulated GTH release from goldfish pituitary cells: protein kinase C, but not cyclic AMP is an important mediator of GnRH-stimulated gonadotropin secretion in goldfish. Gen Comp Endocrinol (1996) 0.75
Evaluating Oregon's beach sites for application to United States Environmental Protection Agency's BEACH Act criteria. Mar Pollut Bull (2004) 0.75
Twice-daily versus once-daily morphine sulphate controlled-release suppositories for the treatment of cancer pain. A randomized controlled trial. Support Care Cancer (1999) 0.75
Differences in the acute actions of sGnRH and cGnRH-II on gonadotropin release in goldfish pituitary cells. Gen Comp Endocrinol (1995) 0.75
Role of methadone in the management of pain in cancer patients. Oncology (Williston Park) (1999) 0.75
Respective limits of palliative care and oncology in the supportive care of cancer patients. Support Care Cancer (1999) 0.75
Interactions of cyclic adenosine 3',5'-monophosphate, protein kinase-C, and calcium in dopamine- and gonadotropin-releasing hormone-stimulated growth hormone release in the goldfish. Endocrinology (1994) 0.75